Tyler Walker
Family · Humble, TXNPI 1003427188
Payments from drug & device makers
Across 51 payments — averaging $35.09 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$330
- Idorsia Pharmaceuticals US Inc$224
- AbbVie$165
- Lilly USA, LLC$127
- Kyowa Kirin, Inc.$121
- Exact Sciences$109
- plus $715 from 15 others
What the payments were for
- Food & beverage$1,790100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 5 | $330 |
| Idorsia Pharmaceuticals US Inc | 6 | $224 |
| AbbVie | 5 | $165 |
| Lilly USA, LLC | 4 | $127 |
| Kyowa Kirin, Inc. | 1 | $121 |
| Exact Sciences | 5 | $109 |
| Organon | 1 | $102 |
| Novo Nordisk | 6 | $101 |
| Alk-abello, Inc | 1 | $99 |
| Pharming Healthcare, Inc. | 1 | $97 |
| Azurity Pharmaceuticals, Inc. | 5 | $87 |
| Lundbeck LLC | 2 | $54 |
| Bolton Medical Inc | 1 | $36 |
| Bayer | 1 | $21 |
| Boehringer Ingelheim | 1 | $20 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $19 |
| Tris Pharma Inc | 1 | $18 |
| Acella Pharmaceuticals, LLC | 1 | $17 |
| Paratek Pharmaceuticals, Inc. | 1 | $15 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
| Currax Pharmaceuticals LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,790 in reported general payments places this provider in the 75th percentile of 15,456 family providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Levothyroxine Sodium | 13 | $824 |
| Valsartan-HydrochlorothiazideValsartan/Hydrochlorothiazide | 12 | $786 |
| Gabapentin | 15 | $427 |
| Metoprolol Succinate | 16 | $425 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 12 | $362 |
| Fluticasone Propionate | 25 | $307 |
| Duloxetine Hcl | 14 | $275 |
| Donepezil Hcl | 11 | $144 |
| Metformin Hcl ErMetformin Hcl | 17 | $133 |
| Montelukast Sodium | 12 | $107 |
| Azithromycin | 12 | $86 |
| Losartan Potassium | 16 | $86 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 11 | $83 |
| Amlodipine Besylate | 11 | $71 |
| Escitalopram Oxalate | 11 | $64 |
Paid to pharmacies, not to this prescriber.
Other family in Humble
- Lashonda CraneHouston$3.4M
- David WeirDallas$959K
- Luba YammineHouston$479K
- Robin BeachHouston$428K
- Nirupama JeromeAustin$418K
- April LopezMcAllen$417K
- Linda MercadoHouston$211K
- Sarah AguilarHouston$199K
- Sie ThomasDallas$197K
- Anna CastroSan Antonio$184K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.